These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21422518)

  • 1. Cognitive aging and early diagnosis challenges in Alzheimer's disease.
    Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():153-9. PubMed ID: 21422518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
    Sarazin M; Dubois B
    Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A guide to diagnosis of Alzheimer's disease].
    Sarazin M; Dubois B
    Rev Prat; 2005 Nov; 55(17):1879-90. PubMed ID: 16396228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological and information processing variability predicts memory decrements associated with normal age-related cognitive decline and Alzheimer's disease (AD).
    Hogan MJ; Carolan L; Roche RA; Dockree PM; Kaiser J; Bunting BP; Robertson IH; Lawlor BA
    Brain Res; 2006 Nov; 1119(1):215-26. PubMed ID: 16997285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment: transition between aging and Alzheimer's disease.
    Petersen RC
    Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cognitive deficits during the transition to Alzheimer's disease.
    Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ
    J Intern Med; 2004 Sep; 256(3):195-204. PubMed ID: 15324363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.
    Sterniczuk R; Antle MC; Laferla FM; Dyck RH
    Brain Res; 2010 Aug; 1348():149-55. PubMed ID: 20558146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease.
    Mickes L; Wixted JT; Fennema-Notestine C; Galasko D; Bondi MW; Thal LJ; Salmon DP
    Neuropsychology; 2007 Nov; 21(6):696-705. PubMed ID: 17983283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.